What Surgnova does

Surgnova Healthcare Technologies is a Beijing-headquartered medical device company founded in January 2015 by former executives of international medical device companies. The company designs, manufactures, and commercializes minimally invasive surgical devices and interventional oncology systems across four product platforms: (1) Tumor Ablation Platform comprising the Dophi series of irreversible electroporation (N3000), microwave (M150E with patented Anti-phase Technology), and radiofrequency (R150E with three-electrode simultaneous ablation) systems; (2) Energy Surgery Platform including the SoniCure ultrasonic scalpel system (with the first NMPA-approved 7mm vascular coagulation device in China), VariCure combined ultrasonic and electrosurgical system, and TriCure ultrasonic/electrosurgical/vessel sealing system; (3) Endoscopy Platform with DeepEye 2D, 3D, and 3D4K fluorescence video endoscopy systems featuring proprietary fog-proof technology; and (4) Surgical Stapling Platform with Alligator powered endoscopic staplers, supplemented by the InflaCure gas insufflator and accessory cart products.

The company holds approximately 60 national invention patents and 10+ international PCT applications, with manufacturing concentrated at a nearly 10,000 sqm production base in Cixi, Zhejiang Province (including 2,000 sqm of Class 100,000 cleanroom) and an R&D center in Beijing featuring more than 10 specialized laboratories. Surgnova has obtained ISO 13485, CE, FDA, and NMPA certifications across multiple products. Revenue mechanics are based on capital equipment hardware sales (ablation generators, ultrasonic generators, endoscopy towers, powered staplers) along with recurring consumables such as electrodes, antennas, transducers, and stapler reloads. Products are sold direct and via an international distributor network covering 50+ countries across Europe, Americas, Asia, Middle East, and Africa, with the Shenzhen Overseas Business Operating Center (opened August 2021) functioning as the globalization hub. The company has raised Angel, Series A, Series A+, and Series B financing between 2014 and 2020, with specific amounts undisclosed.

Name

Surgnova

Legal name

Surgnova Healthcare Technologies

Website

https://surgnova.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Surgnova Healthcare Technologies, founded 2015 in Beijing, designs and manufactures minimally invasive surgical devices and interventional oncology systems — covering tumor ablation (IRE, microwave, RF), ultrasonic and electrosurgical energy, endoscopy, and powered stapling — selling to hospitals globally through direct and distributor channels across 50+ countries.

Ownership category

akta.pro rank

Product category

Minimally Invasive Surgical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Medical Oncology (HLAKAFAB)

Keywords

• Minimally invasive surgery
• Tumor ablation systems
• Ultrasonic surgical devices
• Endoscopic video systems
• Interventional oncology equipment

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Surgical Device Hardware Sales: Sale of capital medical equipment including tumor ablation systems (microwave, radiofrequency, IRE), ultrasonic surgical systems, endoscopy systems, and powered staplers, along with配套 accessories and consumables such as electrodes, antennas, transducers, and stapler reloads.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Surgnova designs, manufactures and sells minimally invasive surgical medical devices for interventional oncology and general surgery. Its portfolio spans four platforms: Tumor Ablation (Dophi IRE, microwave and radiofrequency systems), Energy Surgery (SoniCure ultrasonic scalpel, VariCure and TriCure combined-energy platforms), Endoscopy (DeepEye 2D/3D/4K fluorescence video systems) and Surgical Stapling (Alligator powered endoscopic staplers). Revenue is generated primarily through sale of capital equipment together with reusable accessories and consumables to hospitals and cancer centers.

Product overview

Surgnova Healthcare Technologies provides a comprehensive portfolio of medical devices for minimally invasive surgery and interventional oncology across four main platforms: (1) Tumor Ablation Platform including Dophi™ N3000 Electroporation System (IRE), Dophi™ M150E Microwave Ablation System with patented Anti-phase Technology, and Dophi™ R150E Radiofrequency Ablation System; (2) Energy Surgery Platform featuring SoniCure™ SC100E Ultrasonic Scalpel System and VariCure™ SC300ES Ultrasonic & Electrosurgical System; (3) Endoscopy Platform with DeepEye™ 2D/3D Video Endoscopy Systems and 3D4K Fluorescence systems featuring proprietary fog-proof technology; and (4) Surgical Stapling Platform with Alligator™ Powered Endoscopic Staplers in multiple articulation angles. The portfolio is complemented by accessories including InflaCure™ Gas Insufflator, Foot Switches, and equipment carts. The company positions itself as offering complete minimally invasive surgery solutions, with products used in tens of thousands of procedures globally.

Differentiator

Problem solved

Functional benefit

Brands

• Dophi™: Tumor ablation platform including Electroporation System (IRE), Microwave Ablation System, and Radiofrequency Ablation System
• SoniCure™
• DeepEye™
• Alligator™
• VariCure™
• TriCure™
• InflaCure™

Products and services

• Dophi N3000 Electroporation System New-generation Irreversible Electroporation (IRE) system for non-thermal tumor ablation with real-time tissue temperature monitoring for nerve and blood vessel protection, built-in high-precision pulse synchronization module, and AI-based pre-operative planning and intelligent data management system with report export.
• Dophi M150E Microwave Ablation System Microwave ablation system featuring patented Anti-phase Technology for ultra-spherical ablation with predictability, high precision, reproducibility and safety; dual output channels up to 150W for liver, lung and other tissue ablation procedures.
• Dophi R150E Radiofrequency Ablation System Radiofrequency ablation system with three-electrode simultaneous ablation capacity, intelligent impedance monitoring, full-electrode water cooling design, and 17G/19G electrode options for treatment of tumors in liver, lung, thyroid, breast and bone.
• SoniCure SC100E Ultrasonic Scalpel System Ultrasonic scalpel system providing tissue dissection and vessel sealing with less thermal damage, featuring high-frequency signal tracking and tissue-adaptive technologies; the 7mm coagulation variant is the first NMPA-approved such device in China, and the 52cm variant is the world's longest ultrasonic scalpel.
• VariCure SC300ES Ultrasonic Surgical & Electrosurgical System Multi-functional energy platform integrating ultrasonic, mono-polar pencils, bipolar forceps and hooks into one console for cost-effective tissue dissection and coagulation across open and minimally invasive procedures.
• TriCure Ultrasonic & Electrosurgical & Vessel Sealing System New-generation combined-energy surgical system integrating ultrasonic dissection, electrosurgical and vessel sealing in a single device.
• DeepEye EVS200 3D Video Endoscopy System 3D video endoscopy system providing real 3D perception through dual independent CMOS sensors, with proprietary fog-proof chip-on-tip imaging enhancing procedure precision and safety.
• DeepEye EVS100 2D Video Endoscopy System Compact and portable 2D video endoscopy system with proprietary fog-proof capability, chip-on-tip electronic imaging, and Full HD 1920x1080P resolution for general laparoscopic surgery.
• Alligator Powered Endoscopic Staplers All-electric powered endoscopic staplers featuring electrical control deflection, clamping and firing that enables single-hand operation in complex surgical situations, available in 45-degree, 55-degree and 60-degree articulation angles.
• InflaCure Gas Insufflator CO2 insufflator for laparoscopic surgery featuring a gas heating module, high-flow inflation up to 40L/min, and comprehensive system monitoring for safe pneumoperitoneum establishment.

Quantifiable outcome

• 97.4% primary technique efficacy in stereotactic tumor ablation procedures
• +2 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature7 records

Partnerships

Five partnerships are on record, tiered minor and core.

• VivamusminorChannel Partner/ Reseller/ DistributorPartner for European market distribution, jointly exhibiting at IROS 2020 (International Symposium on Radiological Interventional Oncology) in Salzburg, Austria with Dophi™ Ablation Family products.
• UnifarmaminorChannel Partner/ Reseller/ DistributorTechnical staff support for IRE procedures at ITAC hospital in Argentina, assisting Dr. Kozima with Dophi™ Electroporation System procedures.
• Clínica Universidad de NavarracoreStrategic or Co-development PartnerHost venue for IRE Master Class for prostate focal therapy, bringing together interventional professionals from Spain, Greece, France, Brazil, and Romania for training on IRE procedures.
• International Medical Device DistributorscoreChannel Partner/ Reseller/ DistributorAgent signing ceremonies held in Beijing to establish distributor partnerships for global market coverage. CEO Jindi Zhang conducts R&D center tours and product introductions for prospective agents.
• Korean PartnerminorChannel Partner/ Reseller/ DistributorActive support for showcasing SoniCure™ Ultrasonic Scalpel System at A-PHPBA 2019 (Asian-Pacific Hepato-Pancreato-Biliary Association Congress) in Seoul, Korea.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Johnson & Johnson MedTech (Ethicon): Ethicon's Harmonic ultrasonic scalpels and Echelon staplers directly overlap with Surgnova's ultrasonic and stapling platforms, though as part of a much larger surgical portfolio.
• Karl Storz: Endoscopy and MIS device manufacturer whose video endoscopy and laparoscopic systems overlap with Surgnova's Endoscopy Platform, though privately held and much larger.
• Olympus: Leading endoscopy and minimally invasive surgery company whose video endoscopy systems and energy devices compete with Surgnova's DeepEye™ endoscopy and energy platforms.
• Boston Scientific: Large medical device company with tumor ablation, endoscopy and interventional oncology portfolios that overlap with Surgnova's ablation and endoscopy platforms, but across a far broader product range.
• Medtronic: Global leader in surgical energy devices, staplers, ablation and endoscopy whose Sonicision/Signia and Emprint lines compete with Surgnova's SoniCure, Alligator and Dophi products.
• Stryker: Global surgical technology company with endoscopy, energy and OR equipment lines that overlap with Surgnova's minimally invasive surgery platforms as part of a broad portfolio.

Regional players

• Micro-Tech (Nanjing): Chinese manufacturer of endoscopic and minimally invasive therapeutic devices, comparable in geography, business model, and MIS/endoscopy focus to Surgnova.
• MicroPort Scientific: China-based medical device maker with surgical and interventional device lines and global ambitions, a domestic peer competing in similar minimally invasive segments as Surgnova.
• Nanjing Vison Medical (ECO Microwave): Chinese microwave tumor-ablation device specialist competing directly with Surgnova's Dophi™ microwave ablation offering in the domestic and export ablation market.

Direct peers

• AngioDynamics: Maker of the NanoKnife irreversible electroporation and microwave ablation systems for tumor treatment, directly overlapping with Surgnova's Dophi™ ablation platform in interventional oncology.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/results?search_query=Surgnova

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surgnova